Quarterlytics / Healthcare / Biotechnology / Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP · NASDAQ Healthcare
Claim this profile
Ticker HELP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 50
Overview Research & Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Business description

Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder

Toronto, ON
Is this your company?
Claim profile to control your coverage, no call required.
Company facts
TickerHELP
ExchangeNASDAQ
Sector Healthcare
Industry Biotechnology
Employees50